Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Shaik Nayeem Uddin: Clopidogrel and Omeprazole Combination Can Quietly Reduce A Life-Saving Effect
Shaik Nayeem Uddin/LinkedIn
Apr 1, 2026, 17:19

Shaik Nayeem Uddin: Clopidogrel and Omeprazole Combination Can Quietly Reduce A Life-Saving Effect

Shaik Nayeem Uddin, Global Outreach – Student of the Member American Society for Microbiology, shared a post on LinkedIn:

“A commonly prescribed combination can quietly reduce a life-saving effect.

Let that sink in.

Clopidogrel is a prodrug.
It needs CYP2C19 to become active.

Now introduce Omeprazole.
CYP2C19 gets inhibited, which leads to reduced activation and consequently decreased protection.

What this really means is:
A patient you’re trying to protect from thrombosis may not be getting the full benefit of therapy.

This matters more in:

  • Post-MI patients
  • Stent placements
  • High cardiovascular risk cases

The fix isn’t complicated.
Prefer Pantoprazole when needed

Simple change. Real impact.

Here’s the bigger point:
Drug interactions aren’t rare. They’re routine and often overlooked.

And this is exactly where clinical thinking matters.

This is Part 1 of my series:
Drug Interactions Every Clinician Should Know

If you’re in healthcare, this is something you’ll see more often than you think.

Have you encountered this in clinical practice?”

Shaik Nayeem Uddin

Stay updated with Hemostasis Today.

Antiplatelet Drugs Blood Cardiology clopidogrel CV Risk CYP2C19 Drug Interactions Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Medicine MI Omeprazole Patient Safety Pharmacotherapy Shaik Nayeem Uddin stroke thrombosis
NewsFeed